Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Paclimer Microspheres from Guilford progresses to human studies

Dec. 16, 1999

Novel naturally occurring DNA polymerase beta inhibitor discovered at U. of Virginia

Dec. 16, 1999

Banyu tests improved successor to NB-506

Dec. 16, 1999

COX-2 inhibitor suggested to be active in squamous cell carcinoma

Dec. 16, 1999

MGI Pharma commences phase I weekly dosing study with irofulven

Dec. 16, 1999

Camptosar designated for priority review for new indication

Dec. 16, 1999

FDA advisory committee recommends approval of Celebrex as adjunctive therapy for FAP

Dec. 15, 1999

ODAC votes for approval of Targretin for one indication, against approval for another

Dec. 15, 1999

Water-soluble anticancer oxysterols designed at Shenyang Pharmaceutical University

Dec. 15, 1999

Chinese investigators pursue new radiosensitizing agents

Dec. 15, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...